The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma

The use of oral methotrexate for refractory eosinophilic asthma in a tertiary asthma referral centre, Glenfield Hospital, Leicester, was evaluated between January 2006 and December 2014. The patients (n = 61) were carefully phenotyped at baseline with markers of airway inflammation. In addition, a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bilocca, David, Hargadon, B, Pavord, ID, Green, RH, Brightling, CE, Bradding, P, Wardlaw, AJ, Martin, N, Murphy, AC, Siddiqui, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802657/
https://www.ncbi.nlm.nih.gov/pubmed/28569072
http://dx.doi.org/10.1177/1479972317709650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802657/
https://www.ncbi.nlm.nih.gov/pubmed/28569072
http://dx.doi.org/10.1177/1479972317709650

Ejemplares similares